Change in Insulin Sensitivity and Lipid Profile After Dopamine Agonist Therapy in Patients With Prolactinoma

Background Prolactinomas are prolactin(PRL)-secreting neoplastic lesions that can lead to metabolic disturbances and insulin resistance. We aimed to find the change in insulin sensitivity and lipid profile in prolactinoma patients after dopamine therapy.  Methodology A prospective observational stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalil, Ghayyur, Khan, Feroz A, Jamal, Qazi M, Saleem, Ayesha, Masroor, Hassan, Abbas, Kiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505009/
https://www.ncbi.nlm.nih.gov/pubmed/34660034
http://dx.doi.org/10.7759/cureus.17824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505009/
https://www.ncbi.nlm.nih.gov/pubmed/34660034
http://dx.doi.org/10.7759/cureus.17824

Ejemplares similares